Page 162 - FINAL PROGRAM

P-461 A predictive nomogram based on multiple biomarkers leads to appropriate rFSH starting dose in IVF/ICSI cycles: a randomized controlled trial
A.A. Marino (Italy)
P-462 Should intrauterine insemination be performed before or after ovulation? – A retrospective analysis of 6701 cycles
L. Svenstrup (Denmark)
P-463 Pioglitazone is effective for multiple phenotypes of the Zucker fa/fa rats used as a model of polycystic ovary syndrome with insulin resistance
T. Endo (Japan)
P-464 Resting heart rate changes during the menstrual cycle
V. Högqvist Tabor (Germany)
P-465 The oocyte utilization rate (OUR) a measure of pregnancy potential: multi-centre analysis of 7703 cycles
S. Hamamah (France)
P-466 Anti-Müllerian hormone levels and female fecundity - results from a prospective cohort study comprising 654 women with a follow-up period of four years
H.W. Hvidman (Denmark)
P-467 Oncologists’ and haematologists’ perceptions of fertility-related communication – a nationwide survey
C. Micaux Obol (Sweden)
P-468 Cumulative live birth rates (CLBR) after rst ART cycle including subsequent frozen-thaw cycles in 1050 women attending a randomized trial comparing GnRH-antagonist versus GnRH-agonist protocol
M. Toftager (Denmark)
P-469 Angiotensin-(1-7) in human follicular uid correlates with oocyte maturation
F. Reis (Brazil)
P-470 An approach to calculate the number of MII oocytes required to guaranty IVF success in a fertility preservation programme
F. Prados Mondéjar (Spain)
P-471 Impact of thyroid autoimmunity on fertility outcome in IVF patients
M. De Brucker (Belgium)
158